concentration, the lipophilic cation tetraphenylphosphonium, or Lalanine, which is taken up by electrogenic Na ϩ cotransport) all provoke robust phosphorylation of ERK in LLC-PK1 and MadinDarby canine kidney (MDCK) cells. Importantly, inhibition of ERK prevented the depolarization-induced activation of Rho. Searching for the underlying mechanism, we have identified the GTP/GDP exchange factor GEF-H1 as the ERK-regulated critical exchange factor responsible for the depolarization-induced Rho activation. This conclusion is based on our findings that 1) depolarization activated GEF-H1 but not p115RhoGEF, 2) short interfering RNA-mediated GEF-H1 silencing eliminated the activation of the Rho pathway, and 3) ERK inhibition prevented the activation of GEF-H1. Moreover, we found that the Na ϩ -K ϩ pump inhibitor ouabain also caused ERK, GEF-H1, and Rho activation, partially due to its depolarizing effect. Regarding the functional consequences of this newly identified pathway, we found that depolarization increased paracellular permeability in LLC-PK1 and MDCK cells and that this effect was mitigated by inhibiting myosin using blebbistatin or a dominant negative (phosphorylation incompetent) MLC. Taken together, we propose that the ERK/GEF-H1/Rho/ROK/pMLC pathway could be a central mechanism whereby electrogenic transmembrane transport processes control myosin phosphorylation and regulate paracellular transport in the tubular epithelium. membrane potential; Rho family small GTPases; phospho-myosin; tubular epithelium; Rho exchange factors THE RESTING PLASMA MEMBRANE potential contributes to the maintenance of cellular ionic homeostasis and provides the driving force for electrogenic ion transport. In excitable cells, such as neurons and muscle cells, normal function is associated with large fluctuations of the membrane potential mediated by a variety of ion channels. In nonexcitable cells, where the resting potential is relatively stable, physiological alterations in the potential can result from various electrogenic ion transport processes, such as activation of the Na ϩ -coupled amino acid and glucose cotransporters (31) or stretch-induced channels (55) . In addition, pathological conditions, such as ATP depletion during hypoxia or metabolic substrate deprivation, and oxidative stress can also perturb the normal membrane potential (5, 10, 26) . Thus, while physiological potential changes signify an altered functional state of the cells, a large and sustained depolarization can be associated with injury. In all of these cases, adequate adaptive and protective cellular responses are needed. Therefore, it is not surprising that depolarization, similar to other physical factors, including anisoosmolarity (39) or heat shock (3), was shown to activate various cellular signaling pathways.
Signals initiated by depolarization have been first described in neurons and neuron-like cells (21, 22) . In the past years, however, we (57) and others (12) (13) (14) have shown that depolarization-induced morphological changes occur in epithelia as well. For example, in cultured eye epithelial cells depolarization causes reorganization of F-actin and microtubules and the appearance of intercellular gaps (12, 14) . Chifflet et al. (13) demonstrated that wounding of an epithelial monolayer results in depolarization of the plasma membrane in the cells bordering the wound. The ensuing actin rearrangement likely contributes to wound healing (13) . Our own studies (57) have demonstrated that in LLC-PK1 and Madin-Darby canine kidney (MDCK) kidney tubular cells depolarization elevates phosphorylation of the myosin light chain (MLC). Interestingly, in contrast to neurons, where the depolarization-induced changes are mostly due to influx of Ca 2ϩ through voltage-sensitive channels (e.g., Ref. 21) , MLC phosphorylation in the tubular cells is independent of intracellular Ca 2ϩ . This observation pointed to a mechanism distinct from the classical Ca 2ϩ -myosin light chain kinase (MLCK) pathway. In search of this mechanism, we found that depolarization activates RhoA, a major cytoskeleton-regulating small GTPase, and the ensuing Rho kinase (ROK) activation results in enhanced MLC phosphorylation (57) . Two main questions, however, remained unanswered: the upstream mechanism of Rho activation and the possible effects of depolarization on epithelial transport processes.
With regards to signaling upstream of Rho in tubular epithelium, we (34) have recently shown that ERK mediates TNF-␣-induced Rho activation. Importantly, multiple studies (e.g., Refs. 4, 46, 48) have demonstrated that in neurons and PC12 pheochromocytoma cells depolarization activates ERK. This prompted us to ask whether depolarization could activate ERK in epithelial cells as well and, if so, whether ERK could mediate depolarization-induced Rho activation.
Activation of small GTPases is promoted by GTP/GDP exchange factors (GEFs), which constitutes a large family (50) . Rho GEF(s) regulated by depolarization have not yet been identified. GEF-H1, a microtubule and junction-bound Rho GEF (Refs. 6, 40 and reviewed in Ref. 7) , is a good candidate since 1) it is expressed in tubular cells, 2) it has been implicated in paracellular permeability control in tubular cells (6, 34) , and 3) it was shown to be regulated by ERK (23) . Interestingly, GEF-H1 was also recently found in complex with the AMPA receptor in neurons, which mediates fast synaptic potential changes (35) . In light of these data, we aimed to examine the possible role of GEF-H1 in mediating depolarization-induced effects.
We also wanted to investigate the functional consequences of the depolarization-induced myosin phosphorylation in tubular cells. The phosphorylation state of MLC is a key determinant of transepithelial and paracellular transport processes (32, 36, 54, 60) . Since our previous studies (57) have shown that depolarization, triggered by the electrogenic Na ϩ -alanine transporter, also induces myosin phosphorylation, it was conceivable that depolarization could serve as a coupling signal between electrogenic cotransporters and the paracellular pathway (36) . The possible effects of depolarization on the intercellular junctions and paracellular pathway, however, remained to be established.
Based on this scenario, the aim of the current study was to investigate the mechanisms underlying depolarization-induced Rho activation. We wanted to explore a possible role for the ERK pathway and GEF-H1. We also sought to investigate whether depolarization affects paracellular permeability and whether this effect requires myosin phosphorylation. Here we show that depolarization activates ERK in tubular epithelial cells and that the ERK pathway mediates Rho activation. We have identified GEF-H1 as the exchange factor required for depolarization-induced, ERK-mediated Rho activation. Finally, we found that depolarization elevates paracellular permeability through phospho-MLC.
MATERIALS AND METHODS
Materials and antibodies. PD98059, U0126, and PP2 were from EMD Biosciences (Mississauga, ON, Canada). BAPTA-AM was from Invitrogen (Burlington, ON, Canada). L-alanine, tetraphenylphosphonium chloride (TPP ϩ ), valinomycin, ouabain octahydrate, EGF, (Ϫ)-blebbistatin, and ionomycin (Iono) were from Sigma-Aldrich (St. Louis, MO). BSA was from BioShop Canada (Burlington, ON, Canada). Complete Mini protease inhibitor tablet and PhosSTOP phosphatase inhibitor tablet were from Roche Diagnostics (Laval, QC, Canada), and the BaculoGold protease inhibitor cocktail was from BD Pharmingen (Mississauga, ON, Canada).
Antibodies against the following proteins were used: RhoA, phospho-p44/42 MAPK (ERK1/2; Thr202/Tyr204), ERK1 (used for immunostaining), phospho-MEK1/2 (Ser217/221), total MEK1/2, GEF-H1, p115RhoGEF, di-phosphorylated (Thr18, Ser19) MLC, and total MLC from Cell Signaling Technology (Danvers, MA); ERK1/2 (used for Western blotting) and myc from Santa Cruz Biotechnology (Santa Cruz, CA); GAPDH from EMD Biosciences; Ras from Thermo Fisher Scientific (Nepean, ON, Canada); and histone (H1 ϩ core proteins) from Millipore (Billerica, MA). Peroxidase and Cy3-labeled secondary antibodies were from Jackson ImmunoResearch (West Grove, PA). Protein A/G agarose was from Santa Cruz Biotechnology, and the glutathione-Sepharose beads were from GE Healthcare Lifesciences (Piscataway, NJ). DAPI nucleic acid stain was from Invitrogen.
Cells. LLC-PK1, a kidney proximal tubule epithelial cell line, and MDCKII, a canine distal tubular epithelial cell line, were obtained from the American Type Culture Collection. Both cell lines were maintained in DMEM medium supplemented with 10% FBS and 1% antibiotic suspension (penicillin and streptomycin; Invitrogen) in an atmosphere containing 5% CO 2. Media and cell treatment. The sodium-based medium (referred to as Na ϩ medium) consisted of 130 mM NaCl, 3 mM KCl, 1 mM MgCl 2, 1 mM CaCl2, 5 mM glucose, and 20 mM Na-HEPES pH 7.4. The potassium-based medium (referred to as K ϩ medium) contained 130 mM KCl, 1 mM MgCl 2, 1 mM CaCl2, and 20 mM HEPES pH 7.4. Confluent cells were serum depleted for 3 h in DMEM before the experiments, followed by a 15-min incubation in Na ϩ medium before the indicated treatments.
Vectors and transient transfection. The vectors used were kind gifts from the following investigators: cDNAs encoding for the glutathionetransferase-Rho-binding domain (GST-RBD) portion of Rhotekin and GST-RhoG17A (24) were from Dr. K. Burridge (University of North Carolina, Chapel Hill) and the AA-MLC vector (16) was from Dr. H. Hosoya (Dept. Biological Sciences, Hiroshima University). GFPtagged dominant negative (DN)-K-Ras was described by Yeung et al. (68) . LLC-PK 1 cells were transfected using the transfection reagent FuGENE 6 (Roche Molecular Biochemicals) according to the manufacturer's instructions using 1 g DNA/well for 6-well plates.
Short interfering RNA. The short interfering (si)RNA targeting the sequence in porcine GEF-H1 AACAAGAGCATCACAGCCAAG (obtained from Applied Biosytems/Ambion, Austin, TX) was described earlier (34) . Cells were transfected with 100 nM siRNA oligonucleotide using the Lipofectamine RNAiMAX transfection reagent (Invitrogen) according to the manufacturer's instructions. Control cells were transfected with 100 nM Silencer siRNA negative control #2 (nonrelated siRNA; Applied Biosytems/Ambion). Experiments were performed 48 h after transfection. The levels of GEF-H1 were routinely checked by Western blotting.
Generation of a polyclonal stable AA-MLC cell line. Generation of the AA-MLC expressing cell line was previously described (34) . Briefly, retroviral vectors expressing a nonphosphorylatable, dominant negative version of MLC (in which T18 and S19 were replaced with alanines: AA-MLC) was used to transduce LLC-PK1 cells. Control cells were transduced using the empty vector lacking the AA-MLC insert but harboring G418 resistance. Cells were selected using 1 mg/ml G418 starting at 48 h after transfection. AA-MLC expression was routinely checked by immunofluorescence using an anti-myc antibody and was Ն80%.
Western blotting. Following treatment, cells were lysed on ice with cold lysis buffer (100 mM NaCl, 30 mM HEPES pH 7.5, 20 mM NaF, 1 mM EGTA, and 1% Triton X-100, supplemented with 1 mM Na3VO4, 1 mM PMSF, and protease inhibitors). For the detection of phospho-proteins, the lysis buffer was also supplemented with the PhosSTOP phosphatase inhibitor. SDS-PAGE and Western blotting was performed as described by Kakiashvili et al. (34) . Blots were blocked in TBS containing either 5% BSA or 5% milk and incubated with the primary antibody overnight. Antibody binding was visualized with the corresponding peroxidase-conjugated secondary antibodies and the enhanced chemiluminescence method (kit from GE Healthcare Lifesciences). Where indicated, blots were stripped and reprobed to demonstrate equal loading or detect levels of GEF-H1. As the phospho-ERK (pERK) antibody proved difficult to strip, these blots were first developed using total ERK antibody, followed by reprobing with pERK. Alternatively, in some cases the samples were run in duplicate and one blot was developed for ERK, the other for pERK.
Detection of myosin phosphorylation by urea-glycerol PAGE. Non-, mono-, and di-phosphorylated forms of MLC were separated using nondenaturating urea-glycerol-PAGE as described in our previous studies (57) , with minor modifications. Briefly, confluent LLC-PK1 cells grown in 6-well plates were serum depleted for 3 h and treated as indicated in Fig. 4 . Subsequently, the cells were lysed in ice-cold acetone containing 10% TCA and 10 mM DTT, followed by centrifugation for 5 min at 6,000 rpm (4°C). The resulting pellet was washed with pure acetone, allowed to air dry, and dissolved in 50 l of sample buffer containing 8.02 M urea, 234 mM sucrose, 23 mM glycine, 10.4 mM DTT, 20 mM Tris pH 8.6, and 0.01% bromophenol blue. Samples were separated on a 12% urea-glycerol gel and blotted onto nitrocellulose membrane. MLC was detected by Western blotting using an anti-MLC antibody. Total MLC (i.e., the sum of all 6 bands) was determined by performing densitometry in each lane, and the amount of di-phosphorylated MLC was expressed as a percentage of total MLC in the same lane. This normalization allows direct comparison among the samples and prevents any potential errors that might arise from differences in loading. The blots were stripped and reprobed with an antibody against di-phospho-MLC.
Preparation of nuclear extracts. Nuclear extracts were prepared from confluent layers of LLC-PK1 cells grown on 6-cm dishes, as described by Masszi et al. (43) , using the NE-PER nuclear extraction kit from Pierce Biotechnology (Rockford, IL) according to the manufacturer's recommendation. The nuclear extracts were collected and their protein concentration determined. Samples containing 10 g protein were analyzed by Western blotting. Anti-histone antibody was used to check for equal loading of nuclear proteins.
Preparation of GST-RBD and GST-RhoG17A fusion proteins. GST-RBD (amino acids 7-89 of Rhotekin) and GST-RhoG17A beads were prepared as described by Di Ciano-Oliveira et al. (17) and Kakiashvili et al. (34) . Protein bound to the beads was estimated by SDS-PAGE, followed by Coomassie blue staining, and the beads were kept at 4°C for immediate use or stored frozen in the presence of glycerol.
Rho activity assay. The amount of active RhoA was determined using an affinity precipitation assay with GST-RBD as in our earlier studies (34) . Briefly, confluent LLC-PK 1 cells grown on 6-or 10-cm dishes were treated as indicated in Figs. 3-6. Cells were lysed with ice-cold lysis buffer containing 100 mM NaCl, 50 mM Tris base pH 7.6, 20 mM NaF, 10 mM MgCl2, 1% Triton X-100, 0.5% deoxycholic acid, 0.1% SDS, 1 mM Na3VO4, and protease inhibitors. After centrifugation, aliquots for determination of total RhoA were removed. The remaining supernatants were incubated at 4°C for 45 min with 20 -25 g of GST-RBD beads, followed by extensive washing. Total cell lysates and the RBD-captured proteins were analyzed by Western blotting using RhoA antibody. Results were quantified by densitometry, and the amount of active RhoA in each sample was normalized to the corresponding total RhoA. The data obtained in each experiment were expressed as fold increase compared with the level of the control taken as unity.
Affinity precipitation of activated GEFs. For detection of activated GEF-H1, active GEFs were affinity precipitated from cell lysates using the RhoG17A mutant that cannot bind nucleotide and therefore has high affinity for GEFs (24) as in our earlier work (34) . GEF-H1 or p115RhoGEF in the precipitates was detected by Western blotting. Precipitation with glutathione-Sepharose beads, containing no fusion proteins, resulted in no GEF-H1 or p115RhoGEF precipitation (34) . The GEFs in total cell lysates were also detected for each sample (total GEF-H1 or p115). Precipitated (active) and total GEF-H1 was quantified by densitometry. The amount of active GEF-H1 in each sample was normalized to the corresponding total GEF-H1, and the data obtained in each experiment were expressed as fold increase compared with the control taken as unity.
Ras activity assay. The amount of active Ras was determined using affinity precipitation with the Ras binding domain of the c-Raf kinase coupled to agarose beads (Cytoskeleton). The precipitation assay was performed essentially as the Rho activation assay, using a lysis buffer that contained 150 mM NaCl, 25 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM EDTA, 1% Ipegal CA-630, and 10% glycerol, supplemented with 1 mM Na3VO4 and protease inhibitors. Total cell lysates and the pelleted beads were analyzed by Western blotting using a Ras antibody and quantified as described for Rho.
Immunofluorescence microscopy. Confluent cells grown on coverslips were treated as indicated in Figs. 1-2 and fixed with 4% paraformaldehyde. Immunofluorescent staining was carried out as described by Kakiashvili et al. (34) . Briefly, following permeabilization with Triton X-100, the coverslips were blocked with 3% BSA in PBS, followed by incubation with primary antibody (1:100). Bound antibody was detected using the corresponding fluorescent secondary antibody (1:1,000), which also contained DAPI to counterstain nuclei. Cells were viewed using an Olympus IX81 microscope (Melville, NY) coupled to an Evolution QEi Monochrome camera (Media Cybernetics, Bethesda, MD).
Transepithelial permeability measurements. Control or AA-MLC expressing LLC-PK1 or MDCK cells were grown on Transwell filters (pore size of 0.4 m; Costar) for 1 day after becoming confluent. The medium in both the top and bottom compartments was replaced with Na ϩ medium for 15 min. To treat cells with the K ϩ medium, the medium in both the top and the bottom was replaced. At the same time, the cells were exposed to 2 mg/ml FITC-labeled dextran (4 kDa; Sigma-Aldrich) added to the top compartment. After 3 h, 50-l samples were taken from the bottom compartment, and the fluorescence was determined by a fluorescent microplate reader (Fluoroscan Ascent FL) using 480 and 518 nm as the excitation and emission wavelength, respectively. We have previously shown that under these conditions LLC-PK 1 cells form a size selective barrier and remain impermeable to a 70-kDa FITC-labeled dextran (Sigma-Aldrich; Ref. 34) . The transport of the large molecular weight dextran was unchanged by treatment with K ϩ medium (not shown). Protein assay. Protein concentration was determined by the bicinchoninic acid assay (Pierce Biotechnology) or the Precision Red Advanced Protein Assay (Cytoskeleton) with BSA used as standard.
Densitometry. Films with nonsaturated exposures were scanned and densitometry analysis performed using a GS-800 calibrated densitometer and the "band analysis" option of the Quantity One software (Bio-Rad). For analyzing ERK phosphorylation, in each experiment the densitometric data were expressed as the percentage of the maximal effect. This representation allowed us to compare ERK phosphorylation even in experiments where the basal ERK phosphorylation was small and close to the background.
Statistical analysis. All shown blots and immunofluorescent pictures represent at least three similar experiments. Data are presented as means Ϯ SE of the number of experiments indicated (n). Statistical significance was assessed by one-way ANOVA using the GraphPad Prism software.
RESULTS

Depolarization induces ERK phosphorylation in tubular cells.
To investigate the role of the ERK pathway in mediating the depolarization-induced cytoskeleton remodeling and Rho activation, we first asked whether depolarization can induce ERK activation in tubular cells. Similar to our earlier study (57), we used a high K ϩ concentration containing medium (K ϩ medium) to induce depolarization in LLC-PK 1 and MDCK cells. As shown in Fig. 1A , exposure of the cells to the K ϩ medium resulted in a rapid increase in the amount of pERK in both cell types. In LLC-PK 1 cells, ERK phosphorylation was easily detectable at 2 min, reached a maximum around 10 min, and remained high at later times. This kinetics was very similar to the depolarization-induced myosin phosphorylation shown in our earlier work (57) . The K ϩ medium also enhanced ERK phosphorylation in MDCK cells, showing that the effect is a general phenomenon and is not restricted to the proximal tubular cell line (Fig. 1A, right blot) . The effect of the K ϩ medium on ERK phosphorylation proved to be reversible, as the readdition of Na ϩ medium following treatment with elevated K ϩ gradually reduced ERK phosphorylation to near basal levels within 10 min (Fig. 1B) . Next, to further substantiate that depolarization and not elevated K ϩ concentration per se causes ERK phosphorylation, we induced depolarization using two alternative methods (57) . We (57) have previously shown that addition of the lipophilic cation, tetraphenyl phosphonium (TPP ϩ ) to tubular cells causes rapid depolarization. Figure 1C shows that TPP ϩ induces a fast and sustained elevation of pERK. We also tested the effect of L-alanine, which enters the cells through a Na ϩ -cotransport process and causes depolarization (31, 57) . Challenging cells with 20 mM L-alanine resulted in a rapid increase in ERK phosphorylation (Fig. 1D ). This effect, however, followed different kinetics: after a fast peak, ERK phosphorylation dropped but still remained above the basal level. Importantly, both TPP ϩ and alanine caused enhanced ERK phosphorylation under conditions where the extracellular K ϩ concentration remained constant and low. In summary, three different depolarizing stimuli induce ERK activation in tubular cells.
Next, we performed immunostaining to localize pERK. In resting cells, pERK was barely detectable (Fig. 1E, top left) , which correlates well with the low pERK levels detected by Western blotting. In contrast, K ϩ medium induced a marked increase in pERK both in the cytosol and in the nucleus (Fig.  1E, top right) . Western blotting of total cell lysates and nuclear fractions showed that ERK was present in the nucleus of resting cells. While total ERK levels did not seem to significantly change in the nucleus upon K ϩ treatment, pERK levels gradually increased in parallel with the cytosolic pERK signal (Fig. 1F) . Thus depolarization provokes a rise in pERK both in the cytosol and in the nucleus.
Depolarization-induced ERK activation is Ca 2ϩ independent and Ras dependent. Depolarization-induced ERK activation was previously shown in various neuronal cells (e.g., Refs. 4, 21, 46) . In these cells, Ras and ERK activation was dependent on Ca 2ϩ and calmodulin. Interestingly, we previously found that depolarization does not induce an increase in the intracellular Ca 2ϩ levels in tubular cells (57) . This suggests a different mechanism of ERK activation. To verify this, we examined the role of intracellular Ca 2ϩ in the depolarizationinduced ERK activation. LLC-PK 1 cells were loaded with the calcium chelator BAPTA-AM (30 M), before exposure to K 10 min (B) . B: following the treatment with K ϩ medium, the Na ϩ medium was added back for indicated times. C and D: cells were exposed to 0.5 mM TPP ϩ (C; con, control) or 20 mM L-alanine (D). At the end of the treatments, cells were lysed and total and phosphorylated (p)ERK was detected using Western blotting as described in MATERIALS AND METHODS. Graphs represent densitometric quantification of pERK Western blots. Values are expressed as %maximal effect, taken as 100%. Data are means Ϯ SE (n Ն 3). Where error bars are not visible, they are smaller than the symbol. *P Ͻ 0.05, significance vs. 0 min. E and F: depolarization-induced ERK phosphorylation occurs both in cytosol and nucleus. E: confluent LLC-PK1 layers, grown on coverslips, were incubated with Na ϩ or K ϩ medium for 5 min. Cells were fixed, and pERK was visualized by immunofluorescence as described in MATERIALS AND METHODS. Nuclei were visualized using DAPI. F: LLC-PK1 cells were grown on 6-cm dishes. Following treatment with Na ϩ or K ϩ medium for indicated times, the cells were lysed and nuclear fractions were isolated as described in MATERIALS AND METHODS. The presence of pERK and total ERK in samples containing 10 g protein was tested using Western blotting. An antibody detecting histones was used to show equal loading in the nuclear fractions. medium, to prevent any increase in intracellular Ca 2ϩ levels. As shown in Fig. 2A , ERK phosphorylation induced by the Ca 2ϩ ionophore ionomycin was prevented, showing that BAPTA indeed eliminated increase in intracellular Ca 2ϩ ( Fig.  2A, right) . In contrast, K ϩ medium caused a similar elevation in ERK phosphorylation in control and BAPTA-loaded cells, suggesting that a rise in intracellular Ca 2ϩ is not required for the effect.
Receptor-induced ERK activation is downstream of the Ras/Raf/MEK pathway (49) . However, stretch-induced ERK activation was suggested to be independent of Ras (20) . Therefore, we next examined whether depolarization activates Ras in tubular cells. Ras activation was measured using an affinity precipitation assay with the GST-RBD of c-Raf. As demonstrated in Fig. 2B , depolarization caused a rapid, Ϸ5-fold increase in the level of active Ras. Moreover, phosphorylation of MEK1/2 was also easily detectable in the total cell lysates of the same samples (Fig. 2B) . To examine whether Ras is indeed necessary for the depolarization-induced ERK activation, we transfected LLC-PK1 cells with a GFP-tagged DN-K-Ras and investigated the depolarization-induced ERK phosphorylation by immunofluorescence (Fig. 2C) . While the increase in ERK phosphorylation was readily detectable in the nontransfected cells exposed to high K ϩ medium, the presence of DN-Ras eliminated this effect. Additional experiments verified that the expression of the dominant negative Ras did not affect the level of total ERK (Fig. 2D) . Taken together, these data show that in tubular cells the Ras/Raf/MEK pathway mediates the effect of depolarization, independent of intracellular Ca 2ϩ .
Depolarization-induced Rho activation is mediated by ERK.
We (57) have previously shown that depolarization induces activation of Rho, leading to Rho kinase-dependent MLC phosphorylation. We also found that in tubular cells Rho activation induced by TNF-␣ is ERK dependent (34) . Having established that depolarization induces ERK activation in tubular cells, with kinetics similar to Rho activation, we next asked whether ERK can mediate the depolarization-induced Rho activation. Consistent with our previous findings, K ϩ -induced depolarization caused a Ϸ3.5-7-fold increase in Rho activity (Fig. 3, A and B) , as measured using the precipitation assay with the Rho binding domain of Rhotekin. Importantly, the depolarization-induced Rho activation was strongly inhibited in the presence of two different MEK1/2 inhibitors, PD98059 (Fig. 3A) and U0126 (Fig. 3B) , which are known to prevent ERK activation. These data therefore suggest that the depolarization-elicited activation of Rho is mediated by the MEK/ERK pathway.
Depolarization activates the Rho exchange factor GEF-H1 in an ERK-dependent manner.
The exchange factor mediating depolarization-induced Rho activation has not been identified. GEF-H1 is a key epithelial Rho exchange factor that is regulated by ERK (23, 34) . To explore a potential role of this GEF in the depolarization-induced effects, we first followed changes in its activity. Cells were exposed to K ϩ medium, and active GEFs were precipitated using a Rho mutant (GST-RhoG17A) that exhibits a high affinity for activated GEFs (34) . The presence of precipitated GEF-H1 was detected by Western blot analysis. As shown in Fig. 3C , depolarization induced a Ͼ10- Fig. 2 . A: depolarization-induced ERK activation is Ca 2ϩ independent. Cells were preincubated with 30 M BAPTA-AM in Na ϩ medium for 15 min before exposing them for 5 min to Na ϩ or K ϩ medium (left) or 1 M ionomycin (Iono; right). ERK phosphorylation was detected as in Fig 1. B: Ras is activated by depolarization. Cells grown on 10-cm dishes were incubated with Na ϩ or K ϩ medium for 5 min. Cells were lysed, and the amount of active Ras was determined using the GST-Ras binding domain (RDB) of c-Raf. Precipitated (active) Ras was detected by Western blotting (top). Total cell lysates from the same experiment were also probed with antibodies against Ras, phospho-MEK1/2 (pMEK), total MEK1/2 (MEK), phospho-ERK1/2 (pERK), and total ERK1/2 (ERK). Amount of precipitated (active) Ras was quantified by densitometry and normalized to the amount of total Ras in cell lysate of the same sample. Results in each experiment are expressed as fold increase compared with the values obtained in control cells. Graph shows means Ϯ SE from n ϭ 3 independent experiments. C: Ras mediates ERK activation. Cells were transfected with dominant negative K-Ras coupled to GFP (DN-Ras-GFP). Forty-eight hours later the cells were treated with K ϩ medium for 30 min and pERK was visualized as in A. Images show DN-Ras-GFP and pERK in the same field. Asterisks denote transfected cells. Note that while pERK is easily detectable in nontransfected cells, the presence of DN-Ras prevents the induction of ERK phosphorylation. D: DN-Ras does not affect total ERK levels. Cells were transfected with DN-Ras-GFP as in C. Forty-eight hours after transfection the cells were fixed and ERK was detected by immunostaining. Asterisks denote transfected cells.
fold activation of GEF-H1. Importantly, this depolarizationinduced GEF-H1 activation was prevented by the MEK1/2 inhibitor PD98059 (Fig. 3C) .
To test whether the effect of depolarization on GEF-H1 is specific to this protein, we tested another Rho exchange factor, p115RhoGEF (1). As shown on Fig. 3D, p115RhoGEF was precipitated using RhoG17A under basal conditions, suggesting that it is active in resting cells. However, in contrast to GEF-H1, the amount of active p115 did not increase when cells were stimulated by the K ϩ medium.
GEF-H1 mediates the depolarization-induced activation of the Rho pathway.
Having shown that GEF-H1 is activated by depolarization, we next assessed whether it indeed mediates Rho activation. We used a GEF-H1-specific siRNA that efficiently downregulates the protein (Fig. 4A and Ref. 34 ). Using the RBD precipitation assay, we compared the depolarizationinduced Rho activation in control cells (transfected with a nonrelated siRNA) and in GEF-H1 downregulated cells. As shown in Fig. 4A , in control siRNA-transfected cells K ϩ medium caused easily detectable Rho activation. In contrast, depolarization failed to activate Rho in cells lacking GEF-H1.
We have demonstrated in our previous work (57) that depolarization induces Rho and Rho kinase-dependent MLC phosphorylation. Therefore, we next investigated the effect of GEF-H1 downregulation on the depolarization-induced MLC phosphorylation. Differentially phosphorylated MLC forms were detected using urea-glycerol PAGE. LLC-PK 1 cells contain two isoforms of MLC that exist in non-, mono (Ser 19)-, and di-phosphorylated (Ser19 and Thr18) forms (Fig. 4B) , as shown in our earlier studies (16, 57) . Depolarization, as expected, induced an increase in di-phospho-MLC. Importantly, this effect was eliminated by the GEF-H1 siRNA (Fig. 4B) , verifying the critical role of this exchange factor in the depolarization-induced myosin activation.
To show that the upstream signaling is intact in cells devoid of GEF-H1, we followed ERK phosphorylation in cells treated with nonrelated or GEF-H1 siRNA. As shown on Fig. 4C , GEF-H1 downregulation had no effect on depolarization-induced ERK activation. The increase in pERK levels was identical in cells treated with control or GEF-H1-specific siRNA (Fig. 4C) . Therefore, the observed inhibitory effects of GEF-H1 downregulation are not due to the unresponsiveness of the cells or an inhibition of upstream signaling.
Inhibition of the Na ϩ -K ϩ -ATPase induces ERK phosphorylation partly through depolarization. The function of the Na ϩ -K ϩ -ATPase is indispensable for establishing and maintaining the resting membrane potential, because the pump maintains the transmembrane Na ϩ and K ϩ concentration gradients. In addition, its electrogenic action directly contributes to the resting potential. Interestingly, ouabain, an inhibitor of the Na ϩ medium, as indicated, followed by incubation in Na ϩ or K ϩ medium for 5 min. Amount of active RhoA was determined using a Rhotekin GST-RBD precipitation assay. RhoA in precipitates (active RhoA) and total cell lysates (total RhoA) was detected by Western blotting using a RhoA antibody. C and D: active GEF-H1 or p115RhoGEF was precipitated using the GST-RhoG17A. Precipitated (active) and total GEF-H1 (C) or p115RhoGEF (D) was detected by Western blot. Rho and GEF-H1 blots were quantified by densitometry. Amount of active Rho or GEF-H1 in each sample was normalized to the amount of total RhoA or GEF-H1 in corresponding cell lysates. Results in each experiment are expressed as fold increase compared with the values obtained in control cells. Graphs show means Ϯ SE from n ϭ 3 independent experiments. onstrated that depolarization activates ERK, we wondered whether depolarization might contribute to the effect of ouabain on ERK. We first established the kinetics of ouabaininduced ERK activation in LLC-PK 1 cells. As shown on Fig. 5A , exposure of LLC-PK 1 cells to 1 mM ouabain caused easily detectable ERK activation after 5 min. Moreover, removal of extracellular K ϩ , which blocks the pump, also elicited ERK phosphorylation, suggesting that inhibition of the Na ϩ pump is indeed key for the effect (Fig. 5A, right) . Next, we wanted to test whether depolarization contributes to the ERK-activating effect of ouabain. To achieve this, we clamped the membrane potential using the K ϩ -ionophore valinomycin. As expected, in the presence of 10 mM extracellular K ϩ , valinomycin treatment caused no major change in the basal pERK levels (Fig.  5B) . Importantly, when ouabain was added in the presence of valinomycin, ERK phosphorylation was reduced (by Ϸ50%; P Յ 0.001). To rule out any nonspecific inhibitory effects of valinomycin on the ERK pathway itself, we also tested its effect on the EGF-induced ERK activation (Fig. 5C) . EGF caused identical elevation in the levels of pERK in the absence or presence of valinomycin. These data therefore suggest that depolarization contributes to the ouabain-induced ERK activation.
Ouabain has recently emerged as a signal initiator that binds to the pump and exerts effects in concentrations that are below the pump-inhibiting concentrations (reviewed in Ref. 67) . While ouabain in such low concentration can initiate signaling, it does not induce depolarization (19, 42) . As shown in Fig. 5D , 1 and 10 nM ouabain were indeed able to increase levels of pERK. Moreover, when ERK phosphorylation was induced by 10 nM ouabain, valinomycin did not inhibit but slightly enhanced the response (Fig. 5E ). This finding is in complete agreement with the fact that ouabain at this low concentration does not cause depolarization. Taken together, these data Fig. 4 . GEF-H1 downregulation prevents depolarization-induced activation of the Rho pathway. LLC-PK1 cells were transfected with nonrelated (NR) small interfering (si)RNA or an siRNA designed against porcine GEF-H1. Forty-eight hours after transfection cells were treated with Na ϩ or K ϩ medium for 5 min. A: Rho activation was measured and quantified as in Fig. 3 . GEF-H1 was also detected in the total cell lysates. Graph shows quantification of Rho activation in n ϭ 3 independent experiments (means Ϯ SE). B: myosin light chain (MLC) phosphorylation was detected by urea-glycerol PAGE as described in MATERIALS AND METHODS. Blot was developed with an antibody against total MLC, followed by redeveloping with a di-phospho-MLC antibody. LLC-PK1 cells contain two isoforms of MLC, and each can exist as a non-, mono-, or di-phosphorylated form as labeled (57) . Arrows point to di-phospho-MLC. Graph summarizes densitometric quantification of the changes in di-phospho-MLC. Amount of di-phospho-MLC was expressed as the percentage of the total MLC of the same sample. Results were then expressed as the fold increase compared with the values obtained in control cells (taken as 1). Data represent means Ϯ SE for n ϭ 3 independent experiments. C: GEF-H1 downregulation does not affect depolarization-induced ERK phosphorylation. Cells were transfected with NR or GEF-H1 siRNA as above, treated as indicated, and ERK and pERK were detected as in Fig 1. An antibody against GAPDH was used to verify equal protein loading. Blots of total cell lysates were also developed with a GEF-H1 antibody to verify downregulation. Blots were analyzed using densitometry as in Fig 1. Graphs represent n ϭ 3 independent experiments.
suggest that higher ouabain concentrations stimulate ERK partly through depolarization-independent and partly through depolarization-dependent mechanisms.
Inhibition of the Na ϩ -K ϩ -ATPase induces GEF-H1-dependent Rho activation. While ouabain was shown to affect the cytoskeleton (18, 33) , its effect on Rho is not known. As ouabain potently activates ERK, it was conceivable that it might also activate Rho. Indeed, as shown on Fig. 6 , ouabain treatment causes substantial Rho activation. Importantly, this effect was prevented by downregulation of GEF-H1.
Taken together, these data strongly suggest that inhibition of the Na ϩ pump by ouabain, similar to other depolarizing effects, can activate the ERK/GEF-H1/Rho pathway.
Depolarization elevates paracellular permeability in a phospho-myosin-dependent manner. Myosin phosphorylation is a central regulator of the intercellular junctions that has been shown to mediate elevation in paracellular permeability by a number of chemical and physical factors (32, 36, 45, 54) . In our previous work (36, 57), we raised the possibility that depolarization could serve as a coupling factor mediating the effects of Na ϩ cotransporters on paracellular permeability. To assess whether high K ϩ can indeed lead to enhanced paracellular permeability, we measured the transepithelial transport of small molecular mass (4 kDa) fluorescent dextran, as in our earlier study (34) . Confluent LLC-PK 1 or MDCK layers grown on semipermeable filters were exposed to fluorescent dextran given from the apical side and the transport of dextran through the epithelial layer was assessed by sampling the bottom compartment after 3 h. We (34) have previously shown that in Na ϩ medium both LLC-PK 1 and MDCK cells formed tight monolayers and allowed only a small amount of dextran to permeate through the paracellular pathway throughout a 3-h period. When dextran permeability was followed in the K ϩ medium, fluorescence increased much faster: a 2.9-and 5-fold increase was observed for LLC-PK 1 and MDCK cells, respec- Fig. 6 . Ouabain activates Rho through GEF-H1. Cells were transfected with an NR or GEF-H1-specific siRNA. Cells were treated with 1 mM ouabain in Na ϩ medium, and Rho activation was determined and quantified as in Fig. 3 . All graphs show data from n ϭ 3 experiments (means Ϯ SE). Fig. 5 . Inhibition of the Na ϩ /K ϩ pump by ouabain induces ERK activation partly through depolarization. LLC-PK1 cells were subjected to the following treatments: indicated concentration of ouabain added into the Na ϩ medium for indicated times (A) or 5 min (B, D, and E); K ϩ -free medium for 5 min (A); or 10 g/ml valinomycin with or without ouabain (B and E) or 10 ng/ml EGF for 5 min (C). Where valinomycin (val) was used (B, C, and E), the Na ϩ medium contained 10 mM K ϩ . ERK phosphorylation was detected and quantified as in Fig 1. All graphs show data from n ϭ 3 experiments (means Ϯ SE).
tively (Fig. 7, A and C) . Exposure of LLC-PK 1 cells to alanine also enhanced paracellular permeability, although to a smaller extent (Fig. 7B) .
To test the role of MLC phosphorylation in mediating this permeability increase, we used blebbistatin, a myosin ATPase inhibitor (41, 56) . As shown on Fig. 7C , blebbistatin inhibited the depolarization-induced rise in permeability in a concentration-dependent manner.
To substantiate these results using a nonpharmacological approach, we took advantage of an LLC-PK 1 cell line expressing a mutant, nonphosphorylatable MLC in which threonine 18 and serine 19 were changed to alanines (AA-MLC; Ref. 34) . We have previously shown that this mutant does not disrupt the basal actin cytoskeleton but prevents MLC phosphorylation induced by hyperosmolarity, depolarization, and TNF-␣ (16, 34) . As expected, in control cells expressing the empty vector, K ϩ medium caused an increase in permeability (Fig. 7D) . In contrast, the permeability of AA-MLC expressing cells was unaltered by the K ϩ medium (Fig. 7D) . This, however, was not due to a general unresponsiveness of the cells to depolarization, as ERK phosphorylation induced by the K ϩ medium was indistinguishable in control and AA-MLC expressing cells (Fig. 7E) . Taken together, these data suggest that MLC phosphorylation is indispensable for the depolarization-induced permeability elevation.
DISCUSSION
The resting membrane potential in epithelia contributes to the maintenance of cellular ion concentrations and provides the driving force for ion transport. This function is indispensable for absorption and secretion taking place through epithelial layers. In the past years, however, it has become clear that depolarization of the plasma membrane alters cell morphology and initiates signaling as well. In epithelia, depolarization induces F-actin assembly (12, 14) and myosin phosphorylation (57) . In search for the mechanism mediating these effects, we (57) have shown that depolarization activates the small GTPase Rho in tubular cells. The aim of the present study was to gain insight into the mechanism of Rho activation. Our findings show that depolarization activates ERK, which in turn mediates activation of the Rho exchange factor GEF-H1, leading to Rho activation.
In neuronal cells, depolarization-induced ERK activation has been associated with proliferation and survival (9, 38) and activity-dependent dendrite formation (64) . Here we provide evidence for the first time that depolarization also activates ERK in tubular epithelia. Interestingly, in neurons, depolarization-provoked ERK activation depends on a rise in intracellular Ca 2ϩ (4, 21, 53) . As tubular cells show no changes in intracellular Ca 2ϩ upon depolarization (57), the mechanism for ERK activation likely differs from that observed in neurons. Indeed, the depolarization-induced ERK activation was unaltered when LLC-PK 1 cells were loaded with the Ca 2ϩ chelator BAPTA, verifying the Ca 2ϩ independence of the effect. We also demonstrate that MEK, the enzyme directly upstream of ERK, is activated by depolarization. Two Ras family small GTPases have been implicated in activation of the canonical Raf/MEK/ERK cascade: Rap1 and Ras (28, 49) . We show that depolarization activates Ras in epithelial cells and that Ras is necessary for ERK activation. The question of how Ras is activated by depolarization, however, remains to be answered. One possible scenario is that depolarization might stimulate growth factor receptors, leading to the activation of Ras. Indeed, such growth factor receptor transactivation has been described for other physical factors, including ultraviolet light and hyperosmolarity (30) , as well as for the Na ϩ -pump inhibitor ouabain (67, 69) . In neurons, depolarization-induced ERK activation was found to be PKA dependent (4, 46, 48) . The existence of similar mechanisms and the possible role for PKA in tubular cells remain to be investigated. An alternative but nonexclusive mechanism may implicate the direct potential sensitivity of Ras (68) . Specifically, K-Ras contains a polybasic domain, which is responsible for the surface charge-regulated membrane localization of this GTPase. It remains to be determined whether changes in the transmembrane potential might (indirectly) also affect the distribution/activation of Ras.
One of the key findings of this study is the identification of GEF-H1 as the exchange factor mediating depolarizationinduced Rho activation. GEF-H1, a Rho-specific GEF, binds to the microtubules and cell junctions (7). Our finding that the depolarization-induced GEF-H1 and Rho activation are prevented by MEK inhibition places ERK upstream of GEF-H1 and Rho activation. Indeed, ERK has been shown to associate with and phosphorylate GEF-H1, resulting in enhanced Rho GEF activity (23) . Interestingly, we have previously found that a similar mechanism is responsible for TNF-␣-induced Rho activation (34) . The cross talk between ERK and GEF-H1 therefore seems to be a central and general mechanism for modulating Rho activity and the cytoskeleton by various stimuli in the tubular epithelium. Moreover, as Rho is also involved in the regulation of gene expression and cell cycle (65) , some of the proliferative effects of ERK might be due to its impact on Rho. In this respect, it will be interesting to see whether GEF-H1 and Rho activation contribute to the depolarizationinduced proliferative effects in neurons.
Our studies implicate GEF-H1 as a membrane potentialsensitive GEF in epithelial cells. Interestingly, GEF-H1 and its mouse homologue, Lfc, are highly expressed in the brain as well and are thought to have a role in the development of spine density and neuronal plasticity (35, 51) . Moreover, KCl-induced depolarization results in the translocation of GEF-H1 to the dendritic spines (51) . In addition, GEF-H1 has recently been identified as a component of the AMPA receptor complex (35) , and its activity was shown to negatively regulate spine density and length through RhoA. These data suggest that depolarization of neurons might affect neuronal plasticity through GEF-H1. This intriguing possibility remains to be investigated.
Besides its role as a regulator of Na ϩ and K ϩ homeostasis and membrane potential, the Na ϩ -K ϩ pump has also emerged as a signal initiator (reviewed in Refs. 67, 69). Upon ouabain binding, the pump interacts with various membrane proteins, which leads to activation of Src, the EGF receptor, and the ERK pathway. However, the classic effect of ouabain (when used in the usual 0.5-to 1-mM concentration range) is the inhibition of the Na ϩ pump. This involves the cessation of its electrogenic activity, thereby causing depolarization. Therefore, we wondered whether this depolarizing effect might contribute to ERK activation. To assess this, we clamped the membrane potential using valinomycin during ouabain treatment. This maneuver partially prevented ERK activation by ouabain, suggesting that depolarization is indeed a contributing factor. Our finding that inhibition of the pump by K ϩ removal also results in ERK activation further argues against the notion that the effect is exclusively due to ouabain binding. A significant portion of the effect of ouabain, however, seems to be independent of the potential changes. Indeed, as shown by others (19, 42) , low concentrations of ouabain (1 or 10 nM), which do not cause significant depolarization, also induced ERK activation. This effect however, was not prevented by valinomycin. Moreover, in agreement with other studies (25, 66, 67) , we found that ouabain-induced ERK activation requires Src family kinases, as this effect was eliminated by the Src inhibitor PP2 (not shown). These data substantiate earlier findings that ouabain can stimulate signaling independent of its pump-inhibiting effect and call attention to the fact that ouabain affects ERK by both potentialdependent and -independent pathways.
Another novel finding of this study is that ouabain induces Rho activation in tubular cells, and this effect is mediated by GEF-H1. These findings are in agreement with data from renal arterial smooth muscle cells, where ouabain was shown to induce ROK-dependent myosin phosphorylation and contraction (2) . Interestingly, in HeLa cells ouabain was shown to downregulate the Rho kinase/LIM kinase/cofilin pathway through the MEK/ERK pathway (33) . Strangely, ROK inactivation was not accompanied by a decrease in Rho activity in these studies. While the reason for the apparent discrepancies between the observations made in HeLa and LLC-PK 1 cells is not clear, they might represent cell-type specific differences.
Finally, we considered the effects of depolarization on the epithelial intercellular junctions. Interestingly, apical electrogenic transporters, which can alter the membrane potential, have been shown to enhance paracellular transport. This phenomenon, as described in the intestine, likely increases the efficiency of solute absorption through the epithelial layer (47, 61, 62) . Importantly, the increase in the permeability of the paracellular pathway induced by apical Na ϩ -glucose cotransport was shown to be mediated by myosin phosphorylation (61) . Furthermore, our earlier studies (57) have shown that activation of the Na ϩ -alanine transporter induces depolarization as well as myosin phosphorylation in tubular cells. Based on these studies, we hypothesized that depolarization might serve as the signal that mediates coupling between apical and paracellular transport (36) . The results presented here are in line with this idea. We have found that depolarization indeed enhances paracellular permeability through myosin phosphorylation. Interestingly, although the coupling requires MLC phosphorylation in both intestinal and tubular cells, our current and previous studies reveal that the mechanisms leading to MLC phosphorylation differ in the two cell types. In intestinal epithelium, the apical cotransporters affect MLCK, which is activated through a change in the intracellular pH caused by the combined effects of the Na ϩ -glucose cotransporter and the Na ϩ /H ϩ exchanger (reviewed in Refs. 36, 61) . In contrast, in tubular cells apical Na ϩ -alanine cotransport induces MLC phosphorylation through depolarization, activating Rho and ROK (57) . The current work shows that this occurs through ERK-dependent GEF-H1 activation. Importantly, GEF-H1 can indeed regulate transepithelial and endothelial permeability. GEF-H1 overexpression in MDCK cells resulted in increased paracellular permeability (6) , and it was found to mediate thrombin-induced permeability increase in lung endothelial cells (8) . Unfortunately, we were not able to test the effect of the GEF-H1 siRNA on transepithelial permeability in this study, as under our conditions the tubular cells failed to form a tight monolayer in the absence of GEF-H1 (34) .
Taken together, we propose that the following sequence of events is responsible for the coordination of transport through the apical electrogenic transporters and the paracellular pathway: the electrogenic transporters cause plasma membrane depolarization, which in turn activates the ERK/GEF-H1/Rho/ Rho kinase pathway, leading to enhanced MLC phosphorylation and increased paracellular transport.
While numerous studies have revealed that the junctional acto-myosin complex has a key role in regulating tight junctional permeability (reviewed in Refs. 32, 36, 59, 60) , the underlying mechanism remains elusive. Myosin II in epithelial cells is enriched in the perijunctional actin belt (32) . Junctional transmembrane proteins, including occludin and claudins, are directly or indirectly linked to the junctional actin (27) , and myosin has been shown to directly bind to the tight junction through the adapter protein cingulin (15) . This direct physical contact with the acto-myosin belt raises the possibility that increased myosin-mediated contractility may exert a mechanical effect, physically pulling the junctions apart. In addition, dynamic junction remodeling was also shown to involve altered expression, phosphorylation, endocytosis, and exocytosis of junctional components (11, 27) . These mechanisms might also depend on myosin. Interestingly, various stimuli, including Ca 2ϩ removal (52), IFN-␥ (63), and house dust mites (29), induce MLC-dependent endocytosis of adherens junction proteins. As occludin can also undergo endocytosis (58), our ongoing studies are aimed at testing whether depolarization induces MLC-dependent changes in occludin or claudin traffic.
In summary, we have shown that depolarization-induced activation of the Rho pathway is mediated by ERK and GEF-H1. Depolarization also enhances the paracellular permeability in a phospho-myosin-dependent way. These mechanisms likely play an important role in the regulation of tight junctions and the coordination between transepithelial and paracellular transport.
